GliaPharm is a Swiss biotechnology company that develops treatments for neurological and psychiatric disorders.
GliaPharm est une entreprise suisse de biotechnologies active dans le développement de traitements de maladies neurologiques et psychiatriques.
We made it to the @hellotmrc Global Finals of #HTChallenge! From 4,500 applications we have been named one of the 7 Industrial Biotech track Finalists competing to win at the #HTSummit! Come hear us pitch in Paris on March 14-15.
GliaPharm receives the Cydan Award of the MassChallenge startup Accelerator program in Boston, 2017
GliaPharm has been selected as a Finalist to the MassChallenge Switzerland 2017 startup contest